{"entity":{"type":"insider","cik":"0001743029","url":"/insider/0001743029","json_url":"/insider/0001743029.json","name":"Siu Christine","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":17,"n_filings":7,"first":"2019-03-21","last":"2019-12-11","span_basis":"filed_date"},"name_variants":[{"name":"Siu Christine","source":"filing","n_filings":7,"first_seen":"2019-03-21","last_seen":"2019-12-11"}],"transactions":[{"id":8198187,"accession":"0000899243-19-028932","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-19-028932","line_url":"/filing/0000899243-19-028932","is_derivative":false,"issuer_cik":"0001731831","issuer_name":"Eidos Therapeutics, Inc.","issuer_ticker":"EIDX","issuer_name_source":null,"issuer_url":"/issuer/0001731831","owner_cik":"0001743029","owner_name":"Siu Christine","owner_display_name":"Siu Christine","owner_url":"/insider/0001743029","role":"Officer (CFO and Secretary)","role_mark":"O","role_mark_label":"Officer (CFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":59.65698171,"price_display":"59.66","price_state":"stated","total_value":596569.8171,"total_display":"596,569.82","total_whole":"596,570","shares_owned_after":37371.0,"shares_owned_after_display":"37,371","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-09","filed_date":"2019-12-11","scope":"insider","n_lines":2},{"id":8665159,"accession":"0000899243-19-028602","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000899243-19-028602","line_url":"/filing/0000899243-19-028602","is_derivative":false,"issuer_cik":"0001731831","issuer_name":"Eidos Therapeutics, Inc.","issuer_ticker":"EIDX","issuer_name_source":null,"issuer_url":"/issuer/0001731831","owner_cik":"0001743029","owner_name":"Siu Christine","owner_display_name":"Siu Christine","owner_url":"/insider/0001743029","role":"Officer (CFO and Secretary)","role_mark":"O","role_mark_label":"Officer (CFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":58.694304,"price_display":"58.69","price_state":"stated","total_value":586943.04,"total_display":"586,943.04","total_whole":"586,943","shares_owned_after":37670.0,"shares_owned_after_display":"37,670","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-04","filed_date":"2019-12-05","scope":"insider","n_lines":2},{"id":8665144,"accession":"0000899243-19-028602","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-19-028602","line_url":"/filing/0000899243-19-028602","is_derivative":false,"issuer_cik":"0001731831","issuer_name":"Eidos Therapeutics, Inc.","issuer_ticker":"EIDX","issuer_name_source":null,"issuer_url":"/issuer/0001731831","owner_cik":"0001743029","owner_name":"Siu Christine","owner_display_name":"Siu Christine","owner_url":"/insider/0001743029","role":"Officer (CFO and Secretary)","role_mark":"O","role_mark_label":"Officer (CFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":59.160768,"price_display":"59.16","price_state":"stated","total_value":591607.68,"total_display":"591,607.68","total_whole":"591,608","shares_owned_after":40470.0,"shares_owned_after_display":"40,470","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-03","filed_date":"2019-12-05","scope":"insider","n_lines":3},{"id":8665068,"accession":"0000899243-19-028027","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-19-028027","line_url":"/filing/0000899243-19-028027","is_derivative":false,"issuer_cik":"0001731831","issuer_name":"Eidos Therapeutics, Inc.","issuer_ticker":"EIDX","issuer_name_source":null,"issuer_url":"/issuer/0001731831","owner_cik":"0001743029","owner_name":"Siu Christine","owner_display_name":"Siu Christine","owner_url":"/insider/0001743029","role":"Officer (CFO and Secretary)","role_mark":"O","role_mark_label":"Officer (CFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":54.74562244,"price_display":"54.75","price_state":"stated","total_value":547456.2244,"total_display":"547,456.22","total_whole":"547,456","shares_owned_after":37071.0,"shares_owned_after_display":"37,071","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-22","filed_date":"2019-11-22","scope":"insider","n_lines":2},{"id":8665057,"accession":"0000899243-19-028027","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-19-028027","line_url":"/filing/0000899243-19-028027","is_derivative":false,"issuer_cik":"0001731831","issuer_name":"Eidos Therapeutics, Inc.","issuer_ticker":"EIDX","issuer_name_source":null,"issuer_url":"/issuer/0001731831","owner_cik":"0001743029","owner_name":"Siu Christine","owner_display_name":"Siu Christine","owner_url":"/insider/0001743029","role":"Officer (CFO and Secretary)","role_mark":"O","role_mark_label":"Officer (CFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":55.123072,"price_display":"55.12","price_state":"stated","total_value":1378076.8,"total_display":"1,378,076.80","total_whole":"1,378,077","shares_owned_after":36670.0,"shares_owned_after_display":"36,670","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-21","filed_date":"2019-11-22","scope":"insider","n_lines":2},{"id":8024475,"accession":"0000899243-19-019526","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-19-019526","line_url":"/filing/0000899243-19-019526#line-2","is_derivative":false,"issuer_cik":"0001731831","issuer_name":"Eidos Therapeutics, Inc.","issuer_ticker":"EIDX","issuer_name_source":null,"issuer_url":"/issuer/0001731831","owner_cik":"0001743029","owner_name":"Siu Christine","owner_display_name":"Siu Christine","owner_url":"/insider/0001743029","role":"Officer (CFO and Secretary)","role_mark":"O","role_mark_label":"Officer (CFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":39.37,"price_display":"39.37","price_state":"stated","total_value":196850.0,"total_display":"196,850.00","total_whole":"196,850","shares_owned_after":36470.0,"shares_owned_after_display":"36,470","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-10","filed_date":"2019-07-12","scope":"insider"},{"id":8502907,"accession":"0000899243-19-016042","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-19-016042","line_url":"/filing/0000899243-19-016042","is_derivative":false,"issuer_cik":"0001731831","issuer_name":"Eidos Therapeutics, Inc.","issuer_ticker":"EIDX","issuer_name_source":null,"issuer_url":"/issuer/0001731831","owner_cik":"0001743029","owner_name":"Siu Christine","owner_display_name":"Siu Christine","owner_url":"/insider/0001743029","role":"Officer (CFO and Secretary)","role_mark":"O","role_mark_label":"Officer (CFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17000.0,"shares_display":"17,000","price_per_share":29.96982117647059,"price_display":"29.97","price_state":"stated","total_value":509486.96,"total_display":"509,486.96","total_whole":"509,487","shares_owned_after":19770.0,"shares_owned_after_display":"19,770","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-05","filed_date":"2019-06-07","scope":"insider","n_lines":3},{"id":7909251,"accession":"0000899243-19-011239","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-19-011239","line_url":"/filing/0000899243-19-011239#line-2","is_derivative":false,"issuer_cik":"0001731831","issuer_name":"Eidos Therapeutics, Inc.","issuer_ticker":"EIDX","issuer_name_source":null,"issuer_url":"/issuer/0001731831","owner_cik":"0001743029","owner_name":"Siu Christine","owner_display_name":"Siu Christine","owner_url":"/insider/0001743029","role":"Officer (CFO and Secretary)","role_mark":"O","role_mark_label":"Officer (CFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":26.11,"price_display":"26.11","price_state":"stated","total_value":130550.0,"total_display":"130,550.00","total_whole":"130,550","shares_owned_after":34701.0,"shares_owned_after_display":"34,701","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-04-24","filed_date":"2019-04-26","scope":"insider"},{"id":8049479,"accession":"0000899243-19-008760","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-19-008760","line_url":"/filing/0000899243-19-008760#line-4","is_derivative":false,"issuer_cik":"0001731831","issuer_name":"Eidos Therapeutics, Inc.","issuer_ticker":"EIDX","issuer_name_source":null,"issuer_url":"/issuer/0001731831","owner_cik":"0001743029","owner_name":"Siu Christine","owner_display_name":"Siu Christine","owner_url":"/insider/0001743029","role":"Officer (CFO and Secretary)","role_mark":"O","role_mark_label":"Officer (CFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11913.0,"shares_display":"11,913","price_per_share":19.66,"price_display":"19.66","price_state":"stated","total_value":234209.58,"total_display":"234,209.58","total_whole":"234,210","shares_owned_after":34701.0,"shares_owned_after_display":"34,701","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-19","filed_date":"2019-03-21","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":17,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":17,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":17},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001731831","name":"Eidos Therapeutics, Inc.","url":"/issuer/0001731831","role":"Officer (CFO and Secretary)","n_filings":7,"first_seen":"2019-03-21","last_seen":"2019-12-11"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001743029","retrieved_at":"2026-08-25T00:11:33+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}